Earnings History Data for Atara Biotherapeutics, Inc. (ATRA) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Atara Biotherapeutics, Inc.

Atara Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company. It is focused on developing therapeutics for serious unmet medical needs, with an initial focus on muscle wasting conditions and oncology. The company's lead programs are focused on myostatin and activin, members of the TGF-beta family of proteins that have demonstrated the potential to have therapeutic benefit in a number of clinical indications. Its lead product candidate is PINTA 745, which is in a Phase II clinical trial for the treatment of protein-energy wasting in end-stage renal disease patients. Atara Biotherapeutics, Inc. is headquartered in Brisbane, California.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
09-08-2021 AH 4:00 PM ET
(Aug 9)
ATRA Atara Biotherapeutics, Inc. 1,080 -0.91 -0.88 -1.14 Atara Biotherapeutics EPS beats by $0.02, misses on revenue
[8/9/2021 4:03 PM]
12.75 0.26 
(2.08%)
13.05 0.56 
(4.48%)
11.33 - 28.20 925,166 550,000 4,162
04-05-2021 AH 4:05 PM ET
(May 4)
ATRA Atara Biotherapeutics, Inc. 1,220 -0.86 -0.93 -1.20 Atara Biotherapeutics EPS beats by $0.08, beats on revenue
[5/4/2021 4:27 PM]
13.51 -0.14 
(-1.03%)
14.30 0.65 
(4.76%)
8.39 - 28.20 695,339 1,120,000 7,230
01-03-2021 AH 4:00 PM ET
(Mar 1)
ATRA Atara Biotherapeutics, Inc. 1,380 -0.95 -0.73 -1.36 Atara Biotherapeutics EPS misses by $0.17
[3/1/2021 4:11 PM]
17.07 -0.04 
(-0.20%)
16.70 -0.40 
(-2.37%)
4.52 - 28.20 1,415,410 679,291 1,055
09-11-2020 AH 4:00 PM ET
(Nov 9)
ATRA Atara Biotherapeutics, Inc. 1,030 -0.92 -1.10 -1.31 Atara Biotherapeutics EPS beats by $0.16
[11/9/2020 4:02 PM]
15.55 1.15 
(7.99%)
14.88 0.48 
(3.33%)
4.52 - 19.36 1,417,378 534,695 1,191
05-08-2020 AH 4:00 PM ET
(Aug 5)
ATRA Atara Biotherapeutics, Inc. 915.75 -1.14 -1.21 -1.60 Atara Biotherapeutics EPS in-line
[8/5/2020 4:11 PM]
12.74 0.03 
(0.24%)
13.50 0.79 
(6.22%)
4.52 - 19.36 401,018 778,283 6,623
06-05-2020 AH ATRA Atara Biotherapeutics, Inc. 518.78 -1.20 -1.36 -1.44 0.0 0.0 
(0.00%)
0.0 0.0 
(0.00%)
0.0 - 0.0 0 0 0